Aleksandra Vidisheva

Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment

T. Spektor, J. Lutzky, J. Berenson, 2017, Supportive Care in Cancer.

The anti-myeloma effects of the selective JAK1 inhibitor (INCB052793) alone and in combination in vitro and in vivo

Saurabh Patil, Haiming Chen, J. Berenson, 2019, Annals of Hematology.

Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy

T. Spektor, J. Berenson, J. Treisman, 2016, Supportive Care in Cancer.

Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study

T. Spektor, J. Berenson, Eric Wirtschafter, 2018, European journal of haematology.

The clinical significance of B-cell maturation antigen as a therapeutic target and biomarker

Saurabh Patil, Haiming Chen, J. Berenson, 2018, Expert Review of Molecular Diagnostics.

The anti-myeloma effects of the selective JAK1 inhibitor (INCB052793) alone and in combination in vitro and in vivo

Saurabh Patil, Haiming Chen, J. Berenson, 2019, Annals of Hematology.